Akut mieloid leukémia (AML): vizsgálatok itt: Spanyolország
62 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1. fázisNot yet taking people in SpanyolországBioavailability and Bioequivalence Study of Ziftomenib in Participants With Relapsed/Refractory AML or MDS
- Where
- Barcelona, Madrid, Oviedo, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 126 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT07929740 · EU 2025-524332-19-00 - 1. fázisTaking peopleA Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
- Where
- Barcelona, Madrid, Pamplona
- People
- 225 worldwide
- Run by
- Janssen Cilag International
See details and how to join2026-525234-39-00 · EU 2026-525234-39-00 - 3. fázisTaking peopleBleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
- Where
- Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Lleida, Madrid, Palma, Tarragona, Terrassa, Valencia
- Életkor
- 18 év and over
- People
- 875 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT07223814 · EU 2025-522767-15-00 - 1. fázisTaking peopleA Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML
- Where
- Cáceres, Madrid, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- Charm Therapeutics
See details and how to joinNCT07751991 · EU 2026-526409-14-00 - 1/2. fázisTaking peopleA first time in man study to look at the safety of the experimental drug CCS1477 and what effects it has on cancers that affect the blood, bone marrow, lymph and lymphatic system.
- Where
- Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 16
- Run by
- Cellcentric Limited
See details and how to join2024-519498-20-00 · EU 2024-519498-20-00 - 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Barcelona, Madrid, Pamplona, Salamanca
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 1. fázisTaking peopleFirst-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Genmab
See details and how to joinNCT07384715 · EU 2025-523101-15-00 - 3. fázisTaking peopleAzacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
- Where
- Albacete, Alcalá de Henares, Alicante, Almería, Badalona, Barakaldo, Burgos, Cáceres, Cadiz, Castelló, Córdoba, Donostia / San Sebastian, Hospitalet Del Llobregat, Huelva, Jaén, Las Palmas de Gran Canaria, Lugo, Madrid, Majadahonda, Málaga, Manresa, Murcia, Pamplona, Plasencia, Salamanca, San Sebastián de los Reyes, Santa Cruz de Tenerife, Santander, Santiago de Compostela, Segovia, Seville, Terrassa, Toledo, Valencia, Valladolid, Vigo
- Életkor
- 18 év and over
- People
- 376
- Run by
- PETHEMA Foundation
See details and how to joinNCT07478991 - 3. fázisTaking peopleA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Where
- A Coruña, Barcelona, Cáceres, Jerez de la Frontera, L'Hospitalet de Llobregat, Madrid, Pamplona, Pozuelo de Alarcón, Salamanca, Santander, Seville, Valencia
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06852222 · EU 2024-520154-38-00 - 3. fázisTaking peopleMocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
- Where
- Barcelona, Granada, Las Palmas de Gran Canaria, Madrid, Salamanca, Valencia
- Életkor
- 18 év to 75 év
- People
- 366 worldwide
- Run by
- Priothera SAS
See details and how to joinNCT05429632 - 3. fázisTaking peoplePivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Where
- Badalona, Barcelona, Cáceres, Málaga, Oviedo, Palma de Mallorca, Valencia
- Életkor
- 18 év to 71 év
- People
- 150 worldwide
- Run by
- Quetzal Therapeutics
See details and how to joinNCT07504458 · EU 2025-524810-28-00 - No phaseTaking peopleMaster Framework For Relapse or Refractory Acute Myeloid Leukemia
- Where
- Valencia
- Életkor
- 6 év and over
- People
- 4000 worldwide
- Run by
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT06459024 - 3. fázisTaking peopleIMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
- Where
- Albacete, Alicante, Barcelona, Valencia
- Életkor
- 18 év and over
- People
- 339 worldwide
- Run by
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT06713837 · EU 2024-514517-35-00 - 3. fázisTaking peopleA study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s ineligible for standard induction chemotherapy
- Where
- A Coruña, Albacete, Alcalá de Henares, Alicante, Almería, Badalona, Barakaldo, Barcelona, Bilbao, Burgos, Cáceres, Cadiz, Castello De La Plana, Córdoba, Donostia, Galdakao, Huelva, Jaén, Las Palmas de Gran Canaria, Las Palmas De Gran Canaria, L'Hospitalet de Llobregat, Lugo, Madrid, Majadahonda, Málaga, Manresa, Murcia, Palma, Pamplona, Plasencia, Pozuelo de Alarcón, Salamanca, San Cristóbal de La Laguna, San Sebastián de los Reyes, Santa Cruz de Tenerife, Santander, Santiago de Compostela, Segovia, Sevilla, Terrassa, Toledo, Valencia, Valladolid, Vigo, Vitoria, Zaragoza
- Életkor
- 18 év and over
- People
- 350
- Run by
- Fundacion PETHEMA
See details and how to join2025-522979-29-00 · EU 2025-522979-29-00 - 2/3. fázisTaking peopleA Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Majadahonda, Pamplona, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 660 worldwide
- Run by
- AbbVie
See details and how to joinNCT07581002 · EU 2025-523724-47-00 - 3. fázisTaking peopleA study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia (AML) with a specific gene abnormality who have not previously been treated and who are not eligible for intensive chemotherapy.
- Where
- Badalona, Barcelona, Girona, Valencia
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
See details and how to join2024-512753-24-00 · EU 2024-512753-24-00 - 3. fázisTaking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Alcalá de Henares, Alicante, Badalona, Barcelona, Burgos, Cáceres, Granada, Las Palmas De Gran Canaria, L'Hospitalet de Llobregat, Madrid, Málaga, Oviedo, Palma, Pamplona, Pozuelo de Alarcón, Salamanca, Santander, Sevilla, Tarragona, Valencia
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - 1. fázisTaking peopleEganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS
- Where
- Cáceres, Valencia
- Életkor
- 18 év and over
- People
- 105 worldwide
- Run by
- Stelexis BioSciences
See details and how to joinNCT06533761 · EU 2024-518071-58-00 - 3. fázisTaking peopleTeicoplanin as Infection Prophylaxis in Pediatric Acute Myeloid Leukemia (Pro-Teico study)
- Where
- Alicante, Barcelona, Esplugues De Llobregat, Madrid, Málaga, Palma, Santiago De Compostela, Valencia, Zaragoza
- Életkor
- Up to 64 év
- People
- 128 worldwide
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-506546-23-00 · EU 2023-506546-23-00 - 3. fázisTaking peopleStudies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Where
- Albacete, Badalona, Barcelona, Burgos, Jaén, L'Hospitalet de Llobregat, Madrid, Oviedo, Salamanca, Sevilla, Valencia, Zaragoza
- Életkor
- 18 év and over
- People
- 1300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT07007312 · EU 2025-521314-25-00 - 1/2. fázisTaking peopleMulti-centre Phase 1/2 study testing LB-208 for adults with relapsed/refractory AML or high-risk MDS
- Where
- Barcelona, Cáceres, Madrid, Oviedo, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 60
- Run by
- Aop Orphan Pharmaceuticals GmbH
See details and how to join2025-523396-38-00 · EU 2025-523396-38-00 - 1/2. fázisTaking peopleSafety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 1 év to 17 év
- People
- 70 worldwide
- Run by
- Incyte Biosciences International Sàrl
See details and how to joinNCT03934372 · EU 2023-509699-41-00 - 1/2. fázisTaking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- L'Hospitalet de Llobregat, Sevilla, Valencia
- Életkor
- 30 nap and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - 1. fázisTaking peopleZiftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
- Where
- Barcelona, Madrid
- Életkor
- 0 év to 21 év
- People
- 20 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT06376162 · EU 2023-505262-28-00 - No phaseNot yet taking people in SpanyolországDigital Patient-Reported Assessment in Older Adults With Acute Leukemia
- Where
- Oviedo
- Életkor
- 65 év and over
- People
- 20
- Run by
- Fundación para la Investigación Biosanitaria del Principado de Asturias
See details and how to joinNCT07597590